Shed tirzepatide versus non-GLP-1 medications Shed also offers metformin plus naltrexone plus topiramate ($169/month) and naltrexone plus bupropion ($115/month) as non-GLP-1 weight loss options
Other GLP-1 receptor agonists, different medications, and non-drug treatments can all play a role in managing diabetes and supporting weight loss
Swap sugary drinks for water, include protein with every meal, and focus on fiber-rich, non-starchy vegetables like broccoli, tomatoes, and leafy greens
Meanwhile, an increasingly greater inclination of healthcare providers and payers to consider oral GLP-1 agonists as a positive clinical solution to treat their patients is, first and foremost improving reimbursement coverage scenarios
We honor your individuality at every stage
Cagrilintide had one of the lowest GI odds ratios among incretin-class compounds in a 2025 network meta-analysis, but combination GI burden has not been formally quantified